References

Oxidative stress-induced DNA damage by manganese dioxide nanoparticles in human neuronal cells

10.1155/2017/5478790 · 2017 · External reference

Doxorubicin–loaded pH–responsive porphyrin–derived carbon dots as a promising biocompatible drug delivery system for effective chemotherapy of breast cancer

10.1039/d4ra09058f · 2025 · External reference

Latest nanoparticles to modulate hypoxic microenvironment in photodynamic therapy of cervical cancer: a review of in vivo studies

10.3390/ijms26178503 · 2025 · External reference

Advances in doxorubicin chemotherapy: emerging polymeric nanocarriers for drug loading and delivery

10.3390/cancers17142303 · 2025 · External reference

Assembled gold superstructure triggered synergistic apoptosis/ferroptosis via combined photo–enzyme therapy

10.1021/acsami.5c20328 · 2025 · External reference

Biomedical application of manganese dioxide nanomaterials

2020 · External reference

Folic acid–modified erythrocyte membrane loading dual drug for targeted and chemo–photothermal synergistic cancer therapy

10.1021/acs.molpharmaceut.0c01008 · 2021 · External reference

Self–assembled nano–multiple warheads: a precise targeting platform for combinatorial chemotherapy, PTT and PDT therapy against glioma

10.1016/j.bioadv.2026.215132 · 2026 · External reference

Erythrocyte membrane–liposome coating sustains circulation stability and targeted tumor therapy of CAR–T cells

2026 · External reference

Functions of red cell surface proteins

10.1111/j.1423-0410.2007.00970.x · 2007 · External reference

Red blood cell membrane vesicles for siRNA delivery: a biocompatible carrier with passive tumor targeting and prolonged plasma residency

10.2147/ijn.s504644 · 2025 · External reference

An innovative MWCNTs/DOX/TC nanosystem for chemo–photothermal combination therapy of cancer

10.1016/j.nano.2017.07.002 · 2017 · External reference

Current hurdles to the translation of nanomedicines from bench to the clinic

10.1007/s13346-021-01024-2 · 2022 · External reference

Folate receptor–targeted aminoglycoside–derived polymers for transgene expression in cancer cells

10.1002/btm2.10038 · 2016 · External reference

Emerging nanomedicine strategies for hepatocellular carcinoma therapy

10.1002/imo2.12 · 2024 · External reference

Tumor microenvironment–responsive histidine modified–hyaluronic acid–based MnO2 as in vivo MRI contrast agent

10.1016/j.ijbiomac.2022.12.033 · 2023 · External reference

Erythrocyte membrane–camouflaged doxorubicin nanoparticles for enhancing therapeutic efficacy in primary liver cancer

2026 · External reference

Mitigating doxorubicin–induced cardiotoxicity and enhancing anti–tumor efficacy with a metformin–integrated self–assembled nanomedicine

2025 · External reference

Catalpol ameliorates doxorubicin-induced inflammation and oxidative stress in H9C2 cells through PPAR–γ activation

10.3892/etm.2020.8743 · 2020 · External reference

Folate receptor-targetable and tumor microenvironment-responsive manganese dioxide-based nano-photosensitizer for enhancing hypoxia alleviation-triggered phototherapeutic effects

10.1016/j.jiec.2022.11.065 · 2023 · External reference

A pH–responsive nanocarrier of peanut shell carbon quantum dots as a promising delivery of doxorubicin for cancer therapy

10.1038/s41598-025-06307-z · 2025 · External reference

Manganese dioxide nanowires of tunable dimensions synthesized via a facile hydrothermal route

10.1155/2015/509479 · 2015 · External reference

Targeting strategies for the combination treatment of cancer using drug delivery systems

10.3390/pharmaceutics9040046 · 2017 · External reference

Proteomes of micro- and nanosized carriers engineered from red blood cells

10.1021/acs.jproteome.2c00695 · 2023 · External reference

Recent advances in doxorubicin formulation to enhance pharmacokinetics and tumor targeting

10.3390/ph16060802 · 2023 · External reference

Polydopamine–coated mesoporous silica nanoparticles for multi–responsive drug delivery and combined chemo–photothermal therapy

10.1016/j.msec.2019.110103 · 2019 · External reference

Inhibition of miR–25 attenuates doxorubicin–induced apoptosis, reactive oxygen species production and DNA damage by targeting PTEN

10.7150/ijms.41980 · 2020 · External reference

Imaging study of MnO2-based nanomotors modulating HIF–1α/lipid droplet biogenesis and activating the cGAS–STING pathway

10.3390/bios16050261 · 2026 · External reference

Multifunctional and endogenous stimuli-responsive vinblastine sulfate/manganese dioxide nanodrugs for enhancing chemotherapeutic efficacy against hypoxic tumors

2025 · External reference

Paeoniflorin–copper–coordinated nanoparticles targeting dual organelles induce lung cancer apoptosis

10.1021/acs.molpharmaceut.5c01528 · 2026 · External reference

Oral delivery of a CD44–targeted polydopamine nanoplatform for synergistic chemo–chemodynamic colon cancer therapy: preparation, characterization, and in vitro study

2026 · External reference

A tumor microenvironment–responsive and mannose–mediated MnO2–based nano–delivery system for synergistic targeted chemotherapy in triple–negative breast cancer

10.1016/j.nano.2026.103000 · 2026 · External reference

Red blood cells based nanotheranostics: a smart biomimetic approach for fighting against cancer

10.1016/j.ijpharm.2024.124401 · 2024 · External reference

Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells

10.1007/s13402-024-00969-z · 2025 · External reference

Hollow MnO2 nanosystem for glioblastoma sono–immunotherapy based on blood–brain barrier crossing and oxygen supply strategy

10.1016/j.jcis.2026.140834 · 2026 · External reference

Poly(D,L-lactide-co-glycolide) nanoparticles encapsulating doxorubicin for improved treatment in cholangiocarcinoma and drug-resistant cells

10.1021/acsabm.5c00628 · 2025 · External reference

The development and challenges of PET/MRI dual–modality imaging probes—an update

10.1002/jmri.29779 · 2025 · External reference

Betaine ameliorates doxorubicin–induced cardiomyopathy by inhibiting oxidative stress, inflammation, and fibrosis through the modulation of AMPK/Nrf2/TGF–β expression

10.1002/tox.24291 · 2024 · External reference

Biomedical applications of MnO2 nanomaterials as nanozyme–based theranostics

10.1016/j.biopha.2023.114833 · 2023 · External reference

PEGylation of metal oxide nanoparticles modulates neutrophil extracellular trap formation

10.3390/bios12020123 · 2022 · External reference

MnO2 nanoflowers as a multifunctional nano–platform for enhanced photothermal/photodynamic therapy and MR imaging

10.1039/d1bm00033k · 2021 · External reference

Elevated production of mitochondrial reactive oxygen species via hyperthermia enhanced cytotoxic effect of doxorubicin in human breast cancer cell lines MDA–MB–453 and MCF–7

10.3390/ijms21249522 · 2020 · External reference

Red blood cells: supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems

10.1016/j.addr.2016.02.007 · 2016 · External reference

Overcoming multidrug resistance by a combination of chemotherapy and photothermal therapy mediated by carbon nanohorns

10.1039/c6tb01469k · 2016 · External reference

Copper peroxide/manganese dioxide nanoparticles crosslinked hyaluronan hydrogel for enhanced chemodynamic/photodynamic/photothermal therapy in breast cancer

10.1016/j.jcis.2025.139121 · 2026 · External reference

Phenylboronic acid modification augments the lysosome escape and antitumor efficacy of a cylindrical polymer brush-based prodrug

10.1021/jacs.1c09741 · 2021 · External reference

Surface–modified nanoerythrocyte loading DOX for targeted liver cancer chemotherapy

10.1021/acs.molpharmaceut.8b00881 · 2018 · External reference

Colloidal quantum dots with enhanced reactive oxygen species generation for photodynamic therapy by hydrogen peroxide via deionization

10.1016/j.jcis.2025.138432 · 2025 · External reference

Advances in lysosomal escape mechanisms for gynecological cancer nano-therapeutics

10.1016/j.jpha.2024.101119 · 2024 · External reference

Ultrasound–activated erythrocyte membrane–camouflaged Pt (II) layered double hydroxide enhances PD–1 inhibitor efficacy in triple–negative breast cancer through cGAS–STING pathway–mediated immunogenic cell death

10.7150/thno.102284 · 2025 · External reference

Red blood cell membrane–camouflaged nanoparticles: a novel drug delivery system for antitumor application

10.1016/j.apsb.2019.01.011 · 2019 · External reference

Sauchinone preserves cardiac function in doxorubicin–induced cardiomyopathy by inhibiting the NLRP3 inflammasome

10.1016/j.phymed.2025.156624 · 2025 · External reference

Stacking of doxorubicin on folic acid-targeted multiwalled carbon nanotubes for in vivo chemotherapy of tumors

10.1080/10717544.2018.1501120 · 2018 · External reference

PLLA@PDA–DOX nanobubbles for ultrasound imaging combined chemo–photothermal therapy

10.3390/biom16060834 · 2026 · External reference

Development of ligand modified erythrocyte coated polydopamine nanomedicine to codeliver chemotherapeutic agent and oxygen for chemo-photothermal synergistic cancer therapy

10.1016/j.ijpharm.2022.122156 · 2022 · External reference

Cisplatin–loaded mesoporous polydopamine nanoparticles capped with MnO2 and coated with platelet membrane provide synergistic anti–tumor therapy

10.1016/j.ijpharm.2024.124093 · 2024 · External reference

Folic acid-modified nanoerythrocyte for codelivery of paclitaxel and tariquidar to overcome breast cancer multidrug resistance

10.1021/acs.molpharmaceut.9b01148 · 2020 · External reference

NIR–responsive polydopamine–based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo–photothermal therapy

10.1016/j.actbio.2022.03.051 · 2022 · External reference

Coronary atherosclerosis and chemotherapy: from bench to bedside

2023 · External reference

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery

10.1038/s41467-022-31171-0 · 2022 · External reference

Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics

10.1186/s12951-021-01131-9 · 2021 · External reference